femapent2.5mg30tab

Femapent 2.5 mg is an oral endocrine therapy containing Letrozole, a non-steroidal aromatase inhibitor. It is primarily prescribed for the treatment of hormone receptor-positive breast cancer in postmenopausal women. By blocking the aromatase enzyme, it significantly reduces systemic estrogen levels, thereby slowing down or stopping the growth of hormone-sensitive breast cancer cells. It is also commonly used under medical supervision for ovulation induction in fertility treatments.